| HealthPartners | Oncology - isatuximab-irfc (Sarclisa®) – Minnesota | 2025-07-01 |
| HealthPartners | Oncology - long-acting G-CSF | 2025-07-01 |
| HealthPartners | Oncology - long-acting G-CSF – Minnesota Health | 2025-07-01 |
| HealthPartners | Oncology - pembrolizumab (Keytruda®), | 2025-07-01 |
| HealthPartners | Oncology - sacituzumab govitecan-hziy (Trodelvy™) – | 2025-07-01 |
| HealthPartners | Oncology - trastuzumab (Herceptin®, Herzuma®, | 2025-07-01 |
| HealthPartners | Oncology** - rituximab (Rituxan®, Ruxience™, | 2025-07-01 |
| HealthPartners | Oncology** - rituximab (Rituxan®, Ruxience™, | 2025-07-01 |
| HealthPartners | Pegloticase (Krystexxa®) | 2025-07-01 |
| HealthPartners | Pegloticase (Krystexxa®) - Minnesota Health Care | 2025-07-01 |